Samira Syed

Samira Syed

Auto-generated profile, based on publicly available information

Samira Syed

Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Journal of Urology
Verified
Journal Article
Closed access
PDF file
JHJavier Hernáandez
Javier Hernáandez
SSSamira Syed
Samira Syed
GWGeoffrey Weiss
Geoffrey Weiss
GFGabriel Fernandes
Gabriel Fernandes
DMDendra von Merveldt
Dendra von Merveldt
ITIan M. Thompson
Ian M. Thompson
Studies suggest that vitamin E may decrease the risk of prostate cancer. The Prevention Research Veteran Affairs E-vitamin Nutrition Trial is a randomized, double-blind, placebo controlled study designed to assess the effects of vitamin E supplementation on biomarkers associated with prostate cancer risk in peripheral blood and prostate tissue. A total of 44 patients with increased prostate specific antigen (PSA) and/or abnormal digital rectal examination on initial evaluation were randomized to receive 400 IU vitamin E (22) vs placebo (22). Serum vitamin E, PSA, dehydroepiandrosterone, testosterone and insulin-like growth factor-1 (IGF-1) were measured in the 2 groups at baseline and then at 3-month intervals. Results are reported in 28 patients (placebo in 14 and vitamin E in 14) who completed the treatment as specified by the protocol. Serum Vitamin E was significantly higher in patients on vitamin E supplementation. α-Tocopherol supplementation did not affect the levels of PSA, serum androgens (testosterone and dehydroepiandrosterone) or (IGF-1). Serum α-tocopherol is increased by oral supplementation of vitamin E. We found that α-tocopherol supplementation has no effect on serum androgens, IGF-1 or PSA. The lack of an effect of vitamin supplementation on PSA avoids any bias in the diagnosis of prostate cancer in vitamin E treated patients. Our results suggest that a decrease in prostate cancer risk with α-tocopherol is likely to occur through a mechanism that is nonhormonal and independent of IGF-1.

5 April 2019 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
CBColin Bergstrom
Colin Bergstrom
JPJessica Porembka
Jessica Porembka
YFYisheng Fang
Yisheng Fang
VSVenetia Sarode
Venetia Sarode
SSSamira Syed
Samira Syed

11 August 2022 in Clinical Breast Cancer
Verified
Journal Article
Closed access
SSSidrah Shah
Sidrah Shah
CSChristine Shaing
Christine Shaing
JKJude Khatib
Jude Khatib
WLWilliam Lodrigues
William Lodrigues
JDJulie Dreadin-Pulliam
Julie Dreadin-Pulliam
SSSamira Syed
Samira Syed

5 April 2023 in Current Problems in Cancer: Case Reports
Verified
Journal Article
Open access
SDSharlene Dong
Sharlene Dong
YFYisheng Fang
Yisheng Fang
SSSamira Syed
Samira Syed

19 July 2025 in Clinical Breast Cancer
Verified
Journal Article
Closed access
MSMalcolm Su
Malcolm Su
SSStevie Saxon-Filipe
Stevie Saxon-Filipe
CAChul Ahn
Chul Ahn
AGAng Gao
Ang Gao
YFYisheng Feng
Yisheng Feng
SSSamira Syed
Samira Syed

30 June 2025 in Journal of Community Genetics
Verified
Journal Article
Closed access
PDF file
VKVineeth Kommidi
Vineeth Kommidi
MKManasa Kotamraju
Manasa Kotamraju
KCKeerthana Chakka
Keerthana Chakka
SDSharlene Dong
Sharlene Dong
ABAlexa Badalamenti
Alexa Badalamenti
SSSamira Syed
Samira Syed